Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directeddegeneration method

被引:5
|
作者
Han, Seong-Gu [1 ]
Ko, Sanghwan [1 ]
Lee, Won-Kyu [1 ,2 ]
Jung, Sang Taek [1 ]
Yu, Yeon Gyu [1 ]
机构
[1] Kookmin Univ, Dept Chem, 861-1 Jeongneung Dong, Seoul 136702, South Korea
[2] Osong Med Innovat Fdn, New Drug Dev Ctr, Osong Sengmyung Ro 123, Cheongju, Chungbuk, South Korea
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
新加坡国家研究基金会;
关键词
DRUG DESIGN; LIGAND; THERMODYNAMICS; ANTAGONIST; SUBTYPES; ETA;
D O I
10.1038/s41598-017-08096-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
G-protein coupled receptors (GPCRs) play indispensable physiological roles in cell proliferation, differentiation, and migration; therefore, identifying the mechanisms by which ligands bind to GPCRs is crucial for developing GPCR-targeting pharmaceutics and for understanding critical biological functions. Although some structural information is available regarding the interactions between GPCRs and their small molecule ligands, knowledge of how GPCRs interact with their corresponding macromolecule ligands, such as peptides and proteins, remains elusive. In this study, we have developed a novel strategy to investigate the precise ligand recognition mechanisms involved in the interaction of endothelin receptor type A (ETA) with its ligand, endothelin-1 (ET-1); we call this method "directed degeneration" method. Through flow cytometric screening of a randomized ETA library, statistical analysis of the identified sequences, and biochemical studies, the ligand interaction map was successfully obtained.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Inhibitors of the receptor A for endothelin-1
    Villers, A.
    Neuzillet, Y.
    Beuzeboc, P.
    PROGRES EN UROLOGIE, 2010, 20 : S77 - S79
  • [12] Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria
    Lehrke, I
    Waldherr, R
    Ritz, E
    Wagner, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (11): : 2321 - 2329
  • [13] Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?
    Ozdogan, O
    Goren, Z
    Tozun, N
    Moini, H
    Bilsel, S
    Celikel, C
    Kalayci, C
    Berkman, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1354 - A1354
  • [14] The role of endothelin-1 and endothelin receptor antagonists in prostate cancer
    Nelson, JB
    Carducci, MA
    BJU INTERNATIONAL, 2000, 85 : 45 - 48
  • [15] Effect of endothelin-1 and endothelin receptor blockade on the release of microparticles
    Jung, Christian
    Lichtenauer, Michael
    Wernly, Bernhard
    Franz, Marcus
    Goebel, Bjoern
    Rafnsson, Arnar
    Figulla, Hans-Reiner
    Pernow, John
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (08) : 707 - 713
  • [16] Expression of Endothelin-1 and Endothelin Receptor A in Canine Ovarian Tumours
    Borzacchiello, G.
    Mogavero, S.
    Tortorella, G.
    Catone, G.
    Russo, M.
    REPRODUCTION IN DOMESTIC ANIMALS, 2010, 45 (06) : e465 - e468
  • [17] Biotinyl endothelin-1 binding to endothelin receptor and its applications
    Saravanan, K
    Paramasivam, M
    Dey, S
    Singh, TP
    Srinivasan, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (03) : 287 - 293
  • [18] Endothelin-1 and endothelin B receptor expression in pancreatic adenocarcinoma
    Cook, N.
    Brais, R.
    Qian, W.
    Hak, C. Chan Wah
    Corrie, P. G.
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (04) : 309 - 313
  • [19] Endothelin-1/Endothelin A Receptor Signalling in Breast Cancer.
    Tamkus, D.
    Leece, C.
    Gallo, K.
    Madhukar, B. V.
    Dimitrov, N.
    CANCER RESEARCH, 2011, 71
  • [20] ENDOTHELIN-1 AND ENDOTHELIN-B TYPE RECEPTOR ARE INDUCED IN MESANGIAL PROLIFERATIVE NEPHRITIS IN THE RAT
    YOSHIMURA, A
    IWASAKI, S
    INUI, K
    IDEURA, T
    KOSHIKAWA, S
    YANAGISAWA, M
    MASAKI, T
    KIDNEY INTERNATIONAL, 1995, 48 (04) : 1290 - 1297